首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1791224

流动明胶止血剂市场报告：2031 年趋势、预测与竞争分析

Flowable Gelatin Haemostatic Matrix Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年08月14日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球流动明胶止血剂市场前景光明，在神经外科、妇产科、整形外科、一般外科和耳鼻喉科市场都蕴藏着巨大的机会。预计2025年至2031年期间，全球流动明胶止血剂市场的复合年增长率将达到6.7%。该市场的主要驱动力包括：微创手术需求的不断增长、创伤护理中对有效止血剂的需求日益增长，以及医疗应用中对生物衍生材料的日益偏好。

Lucintel 预测，按类型划分，猪明胶预计在预测期内将出现高速成长。
从应用角度来看，普通外科预计将实现最高成长。
按地区划分，预计北美将在预测期内实现最高成长。

透过一份超过 150 页的综合报告获取宝贵的见解，为您的业务决策提供资讯。

流动明胶止血剂市场的新趋势

流动明胶止血剂市场受到各种新兴趋势的影响，旨在最大限度地提高止血功效、优化操作性能并扩大临床应用。

与活性止血剂合併使用以提高疗效：另一个重要趋势是将流动明胶止血剂与凝血酶、纤维蛋白原和氧化纤维素等活性止血剂联合使用，旨在产生协同作用，从而更快、更有效的止血，特别是在困难出血的情况下。
设计易于使用的产品：设计无需復溶或配製的即用型流动明胶止血剂正日益受到重视。此类配方提高了便利性，减少了手术室操作时间，并降低了配製错误的风险。
与抗菌剂联合使用，最大程度降低感染风险：目前，抗菌剂与流动明胶止血剂联合使用已成为一种新趋势，旨在同时达到止血效果并最大程度降低手术部位感染的风险，这是术后护理的关键问题。
提高生物分解性和组织整合性：目前正在进行研究，以最大程度地提高流动明胶止血剂的生物分解性，确保其完全吸收，不会留下可能阻碍癒合或引起副作用的残留物。增强组织整合性也是一项主要目标。
注射和靶向输送系统的开发：注射和靶向输送系统的开发代表着一种日益增长的趋势，即製造可流动的明胶止血剂，可以以微创的方式输送，或使用专门的施用器或导管标靶化到特定的出血部位，从而进一步增加其在腹腔镜和内视镜手术中的应用。

这些趋势正在改变流动明胶止血剂市场，推动创新，开发止血性能更佳、使用更便利、感染风险更低、且适用于多种外科专业的产品。对联合治疗、即用型、抗菌活性、优化的生物分解性和先进输送系统的重视，正在推动改善手术效果和保护患者。

流动明胶止血剂市场的最新趋势

流动明胶止血剂产业的特点是不断研究，旨在最大限度地提高材料性能及其在手术室中的应用。

先进的明胶加工製程：一项关键的进步是明胶加工製程的改进，从而生产出粒径、孔隙率和膨胀能力最大化的止血剂。这些改进增加了血小板黏附和聚集的表面积，从而实现更有效的止血。
交联明胶止血剂的开发：人们也在研究明胶分子的交联，以提高流动止血剂材料的机械强度和抗劣化能力，从而实现更持久的止血效果，特别是在高流量出血情况下。
整合成像剂以实现术中可视化：一家公司正在探索将成像剂加入可流动明胶止血剂中，以使用类似于萤光成像的方法改善所应用材料的术中可视化。
製造具有可控膨胀特性的止血钳：流动明胶止血钳的最大膨胀能力必须得到控制，以促进伤口癒合，同时避免对邻近组织造成过大压力。目前，技术进步正在实现可控膨胀或预先编程膨胀。
引入符合人体工学的精确输送系统：各公司正在努力开发易于使用的输送系统，包括带有细预填充的预填充施用器，以便将流体明胶止血剂精确且可控地应用于出血部位，即使在难以触及的区域。

这些进步显着影响了流动明胶止血剂市场，为外科医生提供了更有效率、更灵活、更便利的工具，以实现快速、一致的止血。目前，人们专注于明胶特性的最佳化、交联、术中可视化、可控制肿胀和标靶输送，以改善手术效果和病患安全。

The future of the global flowable gelatin haemostatic matrix market looks promising with opportunities in the neurosurgery, obstetrics & gynecology, orthopedic, general surgery, and otolaryngology markets. The global flowable gelatin haemostatic matrix market is expected to grow with a CAGR of 6.7% from 2025 to 2031. The major drivers for this market are the rising demand for minimally invasive surgeries, the growing need for effective hemostatic agents in trauma care, and the increasing preference for biologically-derived materials in medical applications.

Lucintel forecasts that, within the type category, porcine gelatin is expected to witness higher growth over the forecast period.
Within the application category, general surgery is expected to witness the highest growth.
In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix market is influenced by various emerging trends that are aimed at maximizing their haemostatic effectiveness, optimizing their handling characteristics, and extending their clinical applications.

Combination with Active Hemostatic Agents to Improve Efficacy: Another important trend involves the combination of flowable gelatin matrices with active haemostatic agents including thrombin, fibrinogen, or oxidized cellulose. These are designed to impart synergistic action, resulting in more rapid and effective hemostasis, especially in difficult bleeding situations.
Design of Ready-to-Use Products for Easy Application: An increased emphasis exists on designing ready-to-use flowable gelatin haemostatic matrices that make reconstitution or preparation unnecessary. Such formulations enhance convenience, shorten operating room time, and lower the potential for preparation mistakes.
Combination with Antimicrobial Agents to Minimize Infection Risk: A new trend is the combination of antimicrobial agents with flowable gelatin haemostatic matrices. This is intended to offer hemostasis while also minimizing the risk of surgical site infection, an important issue in postoperative management.
Biodegradability and Tissue Integration Improvements: Research is aimed at maximizing the biodegradability of flowable gelatin matrices to allow full absorption without residual material that might hinder healing or induce adverse reactions. Enhanced tissue integration is also a primary target.
Injectable and Targeted Delivery System Development: Development of injectable and targeted delivery systems is a growing trend towards creating flowable gelatin haemostatic matrices that are deliverable by minimally invasive methods or targeted to the specific sites of bleeding using special applicators or catheters, further increasing their use in laparoscopic and endoscopic surgery.

These trends are transforming the flowable gelatin haemostatic matrix market by propelling innovation towards products with greater haemostatic performance, better convenience, lower risk of infection, and broader applicability to multiple surgical specialties. The emphasis on combination therapy, ready-to-use presentation, antimicrobial activity, biodegradability optimization, and sophisticated delivery systems is directed at enhancing surgical results and patient protection.

Recent Developments in the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix industry is marked by continuous research aimed at maximizing the material properties and usage in operating rooms.

Advanced Gelatin Processing Methods: One of the important advancements is improvements in the processing of gelatin to produce matrices with maximum particle size, porosity, and swelling capacity. Such refinement results in increased surface area for platelet adhesion and aggregation, thus providing more efficient hemostasis.
Cross-Linked Gelatin Matrix Development: Cross-linking of gelatin molecules is also being investigated to improve the mechanical strength and resistance to degradation of flowable haemostatic matrices. This has the potential to deliver more sustained hemostasis, especially in high-flow bleeding.
Imaging Agent Integration for Intraoperative Visualization: Certain companies are exploring the integration of imaging agents into flowable gelatin haemostatic matrices to enable improved intraoperative visualization of the material applied using methods such as fluorescence imaging.
Production of Matrices with Regulated Swelling Character: The ability of flowable gelatin haemostatic matrices to swell to a maximum requires regulation so as not to build up too much pressure on contiguous tissues while facilitating sealing of wounds. Advances address controlled and pre-programmed swelling.
Introduction of Ergonomic and Accurate Delivery Systems: Companies are working towards the development of easy-to-use delivery systems, including pre-filled applicators with fine tips, enabling accurate and controlled application of the flowable gelatin matrix at the site of bleeding, even in hard-to-reach locations.

These advancements are profoundly affecting the flowable gelatin haemostatic matrix market by offering surgeons more efficient, versatile, and convenient instruments for rapid and consistent hemostasis. The emphasis on optimized gelatin characteristics, cross-linking, intraoperative visualization, controlled swelling, and targeted delivery leads to enhanced surgical outcomes and patient safety.

Strategic Growth Opportunities in the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix market provides some strategic growth opportunities through many of the major surgical applications.

Cardiovascular Surgery: The requirement for efficient and biocompatible haemostatic agents in complicated cardiovascular procedures, such as cardiac and vascular surgeries, is a strong growth opportunity for flowable gelatin haemostatic matrices, especially those with active agents.
Orthopedic Surgery: Maintenance of hemostasis in orthopedic operations, particularly during large joint arthroplasties and spine surgery, is important. The flowable gelatin matrices have a useful place in controlling oozing hemorrhage in such situations and pose a large growing opportunity.
Neurosurgery: Hemostasis in refined neurosurgical interventions demands highly biocompatible materials with favorable application ease. Flowable gelatin matrices pose an effective, safe solution to haemostatic bleeding control within the central nervous system, identifying a major opportunity for growth.
General Surgery and Trauma: The wide variety of general surgical procedures and trauma cases commonly present with major bleeding. Flowable gelatin haemostatic matrices offer a general-purpose solution to achieve hemostasis quickly in these varied situations, offering a huge growth opportunity.
Minimally Invasive Surgery (MIS): Growing use of MIS technologies, including laparoscopy and endoscopy, generates a need for haemostatic products that will be easily delivered via small incisions or endoluminal lumen. Flowable gelatin matrices with sophisticated delivery systems are particularly suited for these uses, providing a major opportunity for growth.

Seizing these strategic growth opportunities necessitates that manufacturers create flowable gelatin haemostatic matrices that are customized to meet the unique demands of each surgical specialty. This involves optimizing the formulation, delivery system, and performance characteristics to meet the distinct challenges and needs of cardiovascular, orthopedic, neurosurgical, general, trauma, and minimally invasive surgeries.

Flowable Gelatin Haemostatic Matrix Market Driver and Challenges

The market for flowable gelatin haemostatic matrices is driven by a mix of factors that promote its use and pose some challenges to its growth and development.

The factors responsible for driving the flowable gelatin haemostatic matrix market include:

1. Growing Number of Surgical Procedures: The growing number of surgical procedures being conducted worldwide, fueled by an aging population and improved surgical techniques, directly boosts the demand for effective haemostatic agents such as flowable gelatin matrices.

2. Increasing Demand for Advanced Hemostatic Products: Surgeons are increasingly demanding advanced haemostatic products that provide quick, consistent, and biocompatible bleeding control over conventional techniques, fueling the use of flowable gelatin matrices.

3. Multifaceted Use Across Different Surgical Specialties: The versatility of flowable gelatin haemostatic matrices in being used across a wide variety of surgical specialties such as cardiovascular, orthopedic, neurosurgery, and general surgery supports their high market demand.

4. Friendly Biocompatibility and Safety Profile: Gelatin is a biocompatible and natural material with an established safety profile, and flowable gelatin matrices are hence a popular choice among surgeons worried about tissue reaction and long-term consequences.

5. Sustained Product Development and Innovation: Active development and research activities aimed at improving the efficacy, workability, and use of flowable gelatin matrices are resulting in better products and increasing their clinical applications.

Challenges in the flowable gelatin haemostatic matrix market are:

1. Competition from Other Advanced Hemostatic Agents: The market for flowable gelatin haemostatic matrices is competitively challenged by other advanced haemostatic products, including oxidized regenerated cellulose, collagen hemostats, and synthetic sealants, which can provide various benefits in certain surgical contexts.

2. Cost Considerations in Healthcare Systems: The price of advanced haemostatic agents, such as flowable gelatin matrices, can be a major determinant, especially in cost-sensitive markets or in those healthcare systems with limited budgets.

3. Proper Training and Usage Protocols: Proper training of surgical personnel on preparation and application methods is crucial for the successful application of flowable gelatin haemostatic matrices to achieve optimal hemostasis with minimal complications.

The rising number of surgical procedures, the increased demand for sophisticated haemostatic products, and the versatility and beneficial biocompatibility of flowable gelatin matrices are prime drivers behind the expansion of this market. Continuous product development further adds to their attractiveness. Nevertheless, competition from other haemostatic agents, economic factors, and the requirement for adequate training create challenges that need to be met by manufacturers and healthcare professionals in order to provide continued and universal acceptance of flowable gelatin haemostatic matrices in surgery.

List of Flowable Gelatin Haemostatic Matrix Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, flowable gelatin haemostatic matrix companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the flowable gelatin haemostatic matrix companies profiled in this report include:
Ferrosan Medical Devices
Baxter
Aegis Lifesciences
Pfizer
Jiangxi Boenrui
Beijing Nashi Biosurgery
Shenzhen HUANOVA

Flowable Gelatin Haemostatic Matrix Market by Segment

The study includes a forecast for the global flowable gelatin haemostatic matrix market by type, application, and region.

Flowable Gelatin Haemostatic Matrix Market by Type [Value from 2019 to 2031]:

Porcine Gelatin
Bovine Gelatin

Flowable Gelatin Haemostatic Matrix Market by Application [Value from 2019 to 2031]:

Neurosurgery
Obstetrics & Gynecology
Orthopedics
General Surgery
Otolaryngology
Others

Flowable Gelatin Haemostatic Matrix Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix market industry is a major area of surgical hemostasis, providing a biocompatible and efficient option for the management of bleeding in a variety of surgical applications. Recent trends throughout the United States, China, Germany, India, and Japan represent a worldwide tendency towards increased efficacy, greater ease of handling, and increased usage. Gelatin processing innovations, the addition of adjunctive haemostatic agents, and developments in delivery systems are primary areas of interest. Market forces are also driven by the expanding number of surgical procedures and the growing need for advanced haemostatic products with fast and consistent bleeding control.

United States: The American market is noted for having a high rate of adoption of state-of-the-art haemostatic technologies and strong product innovation. Some of the recent advances have been the launch of flowable gelatin matrices with improved swelling ability for greater wound sealing and the addition of thrombin or other clotting factors to speed up hemostasis. An emphasis has also been placed on creating products that are simple to prepare and use in a wide range of surgery.
China: The Chinese market is seeing tremendous growth in the medical device market, including haemostatic devices. Recent news includes the expanding domestic production of flowable gelatin matrices, frequently at lower prices. In addition, there is a focus on enhancing the quality and effectiveness of these locally produced products to address the needs of a fast-growing healthcare system.
Germany: Highly technologically advanced in medicine, Germany has a trend in advanced flowable gelatin haemostatic matrices with defined performance attributes and biocompatibility. Some of the recent advancements include gelatin particle size and distribution optimization for increased surface area and clotting rate. User-friendly packaging and delivery forms as well as exact application are also emphasized.
India: The Indian market is experiencing growing acceptance of newer surgical techniques and rising demand for efficient haemostatic agents. Recent trends have been the increasing availability of flowable gelatin matrices from both domestic and foreign suppliers. Increasing emphasis is also being placed on cost-effective products that offer consistent hemostasis in a variety of surgical specialties.
Japan: Japan's market is focusing on high-quality and safety considerations in medical devices. Some new developments include introducing flowable gelatin haemostatic matrices that have improved biodegradability and low tissue reaction. Also emphasized are products that provide immediate and sustained hemostasis to lead to enhanced surgical outcomes as well as minimized postoperative complications.

Features of the Global Flowable Gelatin Haemostatic Matrix Market

Market Size Estimates: Flowable gelatin haemostatic matrix market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Flowable gelatin haemostatic matrix market size by type, application, and region in terms of value ($B).
Regional Analysis: Flowable gelatin haemostatic matrix market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the flowable gelatin haemostatic matrix market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the flowable gelatin haemostatic matrix market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the flowable gelatin haemostatic matrix market by type (porcine gelatin and bovine gelatin), application (neurosurgery, obstetrics & gynecology, orthopedics, general surgery, otolaryngology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Flowable Gelatin Haemostatic Matrix Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Porcine Gelatin: Trends and Forecast (2019-2031)
4.4 Bovine Gelatin: Trends and Forecast (2019-2031)

5. Global Flowable Gelatin Haemostatic Matrix Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Neurosurgery: Trends and Forecast (2019-2031)
5.4 Obstetrics & Gynecology: Trends and Forecast (2019-2031)
5.5 Orthopedics: Trends and Forecast (2019-2031)
5.6 General Surgery: Trends and Forecast (2019-2031)
5.7 Otolaryngology: Trends and Forecast (2019-2031)
5.8 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Flowable Gelatin Haemostatic Matrix Market by Region

7. North American Flowable Gelatin Haemostatic Matrix Market

7.1 Overview
7.2 North American Flowable Gelatin Haemostatic Matrix Market by Type
7.3 North American Flowable Gelatin Haemostatic Matrix Market by Application
7.4 United States Flowable Gelatin Haemostatic Matrix Market
7.5 Mexican Flowable Gelatin Haemostatic Matrix Market
7.6 Canadian Flowable Gelatin Haemostatic Matrix Market

8. European Flowable Gelatin Haemostatic Matrix Market

8.1 Overview
8.2 European Flowable Gelatin Haemostatic Matrix Market by Type
8.3 European Flowable Gelatin Haemostatic Matrix Market by Application
8.4 German Flowable Gelatin Haemostatic Matrix Market
8.5 French Flowable Gelatin Haemostatic Matrix Market
8.6 Spanish Flowable Gelatin Haemostatic Matrix Market
8.7 Italian Flowable Gelatin Haemostatic Matrix Market
8.8 United Kingdom Flowable Gelatin Haemostatic Matrix Market

9. APAC Flowable Gelatin Haemostatic Matrix Market

9.1 Overview
9.2 APAC Flowable Gelatin Haemostatic Matrix Market by Type
9.3 APAC Flowable Gelatin Haemostatic Matrix Market by Application
9.4 Japanese Flowable Gelatin Haemostatic Matrix Market
9.5 Indian Flowable Gelatin Haemostatic Matrix Market
9.6 Chinese Flowable Gelatin Haemostatic Matrix Market
9.7 South Korean Flowable Gelatin Haemostatic Matrix Market
9.8 Indonesian Flowable Gelatin Haemostatic Matrix Market

10. ROW Flowable Gelatin Haemostatic Matrix Market

10.1 Overview
10.2 ROW Flowable Gelatin Haemostatic Matrix Market by Type
10.3 ROW Flowable Gelatin Haemostatic Matrix Market by Application
10.4 Middle Eastern Flowable Gelatin Haemostatic Matrix Market
10.5 South American Flowable Gelatin Haemostatic Matrix Market
10.6 African Flowable Gelatin Haemostatic Matrix Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Flowable Gelatin Haemostatic Matrix Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Ferrosan Medical Devices
- Company Overview
- Flowable Gelatin Haemostatic Matrix Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 Baxter
- Company Overview
- Flowable Gelatin Haemostatic Matrix Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Aegis Lifesciences
- Company Overview
- Flowable Gelatin Haemostatic Matrix Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Pfizer
- Company Overview
- Flowable Gelatin Haemostatic Matrix Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Jiangxi Boenrui
- Company Overview
- Flowable Gelatin Haemostatic Matrix Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.7 Beijing Nashi Biosurgery
- Company Overview
- Flowable Gelatin Haemostatic Matrix Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.8 Shenzhen HUANOVA
- Company Overview
- Flowable Gelatin Haemostatic Matrix Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Flowable Gelatin Haemostatic Matrix Market
Figure 2.1: Usage of Flowable Gelatin Haemostatic Matrix Market
Figure 2.2: Classification of the Global Flowable Gelatin Haemostatic Matrix Market
Figure 2.3: Supply Chain of the Global Flowable Gelatin Haemostatic Matrix Market
Figure 2.4: Driver and Challenges of the Flowable Gelatin Haemostatic Matrix Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 4.1: Global Flowable Gelatin Haemostatic Matrix Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Type
Figure 4.3: Forecast for the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Type
Figure 4.4: Trends and Forecast for Porcine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 4.5: Trends and Forecast for Bovine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 5.1: Global Flowable Gelatin Haemostatic Matrix Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Application
Figure 5.3: Forecast for the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Application
Figure 5.4: Trends and Forecast for Neurosurgery in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 5.5: Trends and Forecast for Obstetrics & Gynecology in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 5.6: Trends and Forecast for Orthopedics in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 5.7: Trends and Forecast for General Surgery in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 5.8: Trends and Forecast for Otolaryngology in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 5.9: Trends and Forecast for Others in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 6.1: Trends of the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Region (2025-2031)
Figure 7.1: Trends and Forecast for the North American Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 7.2: North American Flowable Gelatin Haemostatic Matrix Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2025-2031)
Figure 7.5: North American Flowable Gelatin Haemostatic Matrix Market by Application in 2019, 2024, and 2031
Figure 7.6: Trends of the North American Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2019-2024)
Figure 7.7: Forecast for the North American Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2025-2031)
Figure 7.8: Trends and Forecast for the United States Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 8.1: Trends and Forecast for the European Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 8.2: European Flowable Gelatin Haemostatic Matrix Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2025-2031)
Figure 8.5: European Flowable Gelatin Haemostatic Matrix Market by Application in 2019, 2024, and 2031
Figure 8.6: Trends of the European Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2019-2024)
Figure 8.7: Forecast for the European Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2025-2031)
Figure 8.8: Trends and Forecast for the German Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 9.1: Trends and Forecast for the APAC Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 9.2: APAC Flowable Gelatin Haemostatic Matrix Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2025-2031)
Figure 9.5: APAC Flowable Gelatin Haemostatic Matrix Market by Application in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2019-2024)
Figure 9.7: Forecast for the APAC Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 10.1: Trends and Forecast for the ROW Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Figure 10.2: ROW Flowable Gelatin Haemostatic Matrix Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2025-2031)
Figure 10.5: ROW Flowable Gelatin Haemostatic Matrix Market by Application in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2019-2024)
Figure 10.7: Forecast for the ROW Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Flowable Gelatin Haemostatic Matrix Market
Figure 11.2: Market Share (%) of Top Players in the Global Flowable Gelatin Haemostatic Matrix Market (2024)
Figure 12.1: Growth Opportunities for the Global Flowable Gelatin Haemostatic Matrix Market by Type
Figure 12.2: Growth Opportunities for the Global Flowable Gelatin Haemostatic Matrix Market by Application
Figure 12.3: Growth Opportunities for the Global Flowable Gelatin Haemostatic Matrix Market by Region
Figure 12.4: Emerging Trends in the Global Flowable Gelatin Haemostatic Matrix Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Flowable Gelatin Haemostatic Matrix Market by Type and Application
Table 1.2: Attractiveness Analysis for the Flowable Gelatin Haemostatic Matrix Market by Region
Table 1.3: Global Flowable Gelatin Haemostatic Matrix Market Parameters and Attributes
Table 3.1: Trends of the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 3.2: Forecast for the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Flowable Gelatin Haemostatic Matrix Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 4.4: Trends of Porcine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 4.5: Forecast for Porcine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 4.6: Trends of Bovine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 4.7: Forecast for Bovine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Flowable Gelatin Haemostatic Matrix Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 5.4: Trends of Neurosurgery in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 5.5: Forecast for Neurosurgery in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 5.6: Trends of Obstetrics & Gynecology in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 5.7: Forecast for Obstetrics & Gynecology in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 5.8: Trends of Orthopedics in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 5.9: Forecast for Orthopedics in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 5.10: Trends of General Surgery in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 5.11: Forecast for General Surgery in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 5.12: Trends of Otolaryngology in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 5.13: Forecast for Otolaryngology in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 5.14: Trends of Others in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 5.15: Forecast for Others in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 7.1: Trends of the North American Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 7.2: Forecast for the North American Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 8.1: Trends of the European Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 8.2: Forecast for the European Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 8.7: Trends and Forecast for the German Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 8.8: Trends and Forecast for the French Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 9.1: Trends of the APAC Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 9.2: Forecast for the APAC Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 10.1: Trends of the ROW Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 10.2: Forecast for the ROW Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Flowable Gelatin Haemostatic Matrix Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Flowable Gelatin Haemostatic Matrix Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 10.9: Trends and Forecast for the African Flowable Gelatin Haemostatic Matrix Market (2019-2031)
Table 11.1: Product Mapping of Flowable Gelatin Haemostatic Matrix Suppliers Based on Segments
Table 11.2: Operational Integration of Flowable Gelatin Haemostatic Matrix Manufacturers
Table 11.3: Rankings of Suppliers Based on Flowable Gelatin Haemostatic Matrix Revenue
Table 12.1: New Product Launches by Major Flowable Gelatin Haemostatic Matrix Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Flowable Gelatin Haemostatic Matrix Market

02-2729-4219

+886-2-2729-4219

License/价格

流动明胶止血剂市场报告：2031 年趋势、预测与竞争分析

Flowable Gelatin Haemostatic Matrix Market Report: Trends, Forecast and Competitive Analysis to 2031

目录

第一章执行摘要

第二章 市场概述

第三章：市场趋势与预测分析

4. 全球流动明胶止血剂市场（按类型）

5. 全球流动明胶止血剂市场（按应用）

第六章区域分析

7. 北美流动明胶止血剂市场

8.欧洲流动明胶止血剂市场

9. 亚太地区流动明胶止血剂市场

第十章世界其他地区流动明胶止血剂市场

第十一章 竞争分析

第十二章机会与策略分析

第十三章：价值链主要企业的公司简介

第十四章 附录